527 related articles for article (PubMed ID: 30001945)
1. Changes to oral anticoagulant therapy and risk of death over a 3-year follow-up of a contemporary cohort of European patients with atrial fibrillation final report of the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) pilot general registry.
Boriani G; Proietti M; Laroche C; Diemberger I; Popescu MI; Riahi S; Shantsila A; Dan GA; Tavazzi L; Maggioni AP; Lip GYH;
Int J Cardiol; 2018 Nov; 271():68-74. PubMed ID: 30001945
[TBL] [Abstract][Full Text] [Related]
2. Prognosis and treatment of atrial fibrillation patients by European cardiologists: one year follow-up of the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase (EORP-AF Pilot registry).
Lip GY; Laroche C; Ioachim PM; Rasmussen LH; Vitali-Serdoz L; Petrescu L; Darabantiu D; Crijns HJ; Kirchhof P; Vardas P; Tavazzi L; Maggioni AP; Boriani G
Eur Heart J; 2014 Dec; 35(47):3365-76. PubMed ID: 25176940
[TBL] [Abstract][Full Text] [Related]
3. Contemporary stroke prevention strategies in 11 096 European patients with atrial fibrillation: a report from the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) Long-Term General Registry.
Boriani G; Proietti M; Laroche C; Fauchier L; Marin F; Nabauer M; Potpara T; Dan GA; Kalarus Z; Diemberger I; Tavazzi L; Maggioni AP; Lip GYH; ;
Europace; 2018 May; 20(5):747-757. PubMed ID: 29016832
[TBL] [Abstract][Full Text] [Related]
4. A prospective survey in European Society of Cardiology member countries of atrial fibrillation management: baseline results of EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry.
Lip GY; Laroche C; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Oliveira MM; Mairesse G; Crijns HJ; Simantirakis E; Atar D; Kirchhof P; Vardas P; Tavazzi L; Maggioni AP
Europace; 2014 Mar; 16(3):308-19. PubMed ID: 24351881
[TBL] [Abstract][Full Text] [Related]
5. 'Real-world' management and outcomes of patients with paroxysmal vs. non-paroxysmal atrial fibrillation in Europe: the EURObservational Research Programme-Atrial Fibrillation (EORP-AF) General Pilot Registry.
Boriani G; Laroche C; Diemberger I; Fantecchi E; Popescu MI; Rasmussen LH; Dan GA; Kalarus Z; Tavazzi L; Maggioni AP; Lip GY
Europace; 2016 May; 18(5):648-57. PubMed ID: 26826133
[TBL] [Abstract][Full Text] [Related]
6. 'Real-world' atrial fibrillation management in Europe: observations from the 2-year follow-up of the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase.
Proietti M; Laroche C; Opolski G; Maggioni AP; Boriani G; Lip GYH;
Europace; 2017 May; 19(5):722-733. PubMed ID: 27194538
[TBL] [Abstract][Full Text] [Related]
7. Association between antithrombotic treatment and outcomes at 1-year follow-up in patients with atrial fibrillation: the EORP-AF General Long-Term Registry.
Boriani G; Proietti M; Laroche C; Fauchier L; Marin F; Nabauer M; Potpara T; Dan GA; Kalarus Z; Tavazzi L; Maggioni AP; Lip GYH;
Europace; 2019 Jul; 21(7):1013-1022. PubMed ID: 30904925
[TBL] [Abstract][Full Text] [Related]
8. Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF General Pilot Registry.
Lip GY; Laroche C; Popescu MI; Rasmussen LH; Vitali-Serdoz L; Dan GA; Kalarus Z; Crijns HJ; Oliveira MM; Tavazzi L; Maggioni AP; Boriani G
Europace; 2015 Dec; 17(12):1777-86. PubMed ID: 26321406
[TBL] [Abstract][Full Text] [Related]
9. Arterial hypertension in patients with atrial fibrillation in Europe: A report from the EURObservational Research Programme pilot survey on atrial fibrillation.
Dan GA; Badila E; Weiss E; Laroche C; Boriani G; Dan A; Tavazzi L; Maggioni AP; Crijns HJ; Popescu R; Blommaert D; Streb W; Lip GYH;
Int J Cardiol; 2018 Mar; 254():136-141. PubMed ID: 29407080
[TBL] [Abstract][Full Text] [Related]
10. Antithrombotic therapy use in patients with atrial fibrillation before the era of non-vitamin K antagonist oral anticoagulants: the Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) Phase I cohort.
Huisman MV; Ma CS; Diener HC; Dubner SJ; Halperin JL; Rothman KJ; Teutsch C; Schoof N; Kleine E; Bartels DB; Lip GY;
Europace; 2016 Sep; 18(9):1308-18. PubMed ID: 27335063
[TBL] [Abstract][Full Text] [Related]
11. Use of statins and adverse outcomes in patients with atrial fibrillation: An analysis from the EURObservational Research Programme Atrial Fibrillation (EORP-AF) general registry pilot phase.
Proietti M; Laroche C; Nyvad O; Haberka M; Vassilikos VP; Maggioni AP; Boriani G; Lip GYH;
Int J Cardiol; 2017 Dec; 248():166-172. PubMed ID: 28859841
[TBL] [Abstract][Full Text] [Related]
12. Increased burden of comorbidities and risk of cardiovascular death in atrial fibrillation patients in Europe over ten years: A comparison between EORP-AF pilot and EHS-AF registries.
Proietti M; Laroche C; Nieuwlaat R; Crijns HJGM; Maggioni AP; Lane DA; Boriani G; Lip GYH; ;
Eur J Intern Med; 2018 Sep; 55():28-34. PubMed ID: 29778588
[TBL] [Abstract][Full Text] [Related]
13. Quality of life and patient satisfaction in patients with atrial fibrillation on stable vitamin K antagonist treatment or switched to a non-vitamin K antagonist oral anticoagulant during a 1-year follow-up: A PREFER in AF Registry substudy.
De Caterina R; Brüggenjürgen B; Darius H; Köhler S; Lucerna M; Pecen L; Renda G; Schilling RJ; Schliephacke T; Zamorano JL; Le Heuzey JY; Kirchhof P
Arch Cardiovasc Dis; 2018 Feb; 111(2):74-84. PubMed ID: 28942115
[TBL] [Abstract][Full Text] [Related]
14. Heart failure in patients with atrial fibrillation in Europe: a report from the EURObservational Research Programme Pilot survey on Atrial Fibrillation.
Lip GY; Laroche C; Popescu MI; Rasmussen LH; Vitali-Serdoz L; Dan GA; Kalarus Z; Crijns HJ; Oliveira MM; Tavazzi L; Maggioni AP; Boriani G
Eur J Heart Fail; 2015 Jun; 17(6):570-82. PubMed ID: 25727992
[TBL] [Abstract][Full Text] [Related]
15. Regional differences in presentation and treatment of patients with atrial fibrillation in Europe: a report from the EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry.
Lip GY; Laroche C; Boriani G; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Oliveira MM; Mairesse G; Crijns HJ; Simantirakis E; Atar D; Maggioni AP; Tavazzi L
Europace; 2015 Feb; 17(2):194-206. PubMed ID: 25149078
[TBL] [Abstract][Full Text] [Related]
16. Management and prognosis of atrial fibrillation in diabetic patients: an EORP-AF General Pilot Registry report.
Fumagalli S; Said SA; Laroche C; Gabbai D; Boni S; Marchionni N; Boriani G; Maggioni AP; Musialik-Lydka A; Sokal A; Petersen J; Crijns HJGM; Lip GYH;
Eur Heart J Cardiovasc Pharmacother; 2018 Jul; 4(3):172-179. PubMed ID: 29309557
[TBL] [Abstract][Full Text] [Related]
17. Impact of chronic obstructive pulmonary disease on prognosis in atrial fibrillation: A report from the EURObservational Research Programme Pilot Survey on Atrial Fibrillation (EORP-AF) General Registry.
Proietti M; Laroche C; Drozd M; Vijgen J; Cozma DC; Drozdz J; Maggioni AP; Boriani G; Lip GY;
Am Heart J; 2016 Nov; 181():83-91. PubMed ID: 27823697
[TBL] [Abstract][Full Text] [Related]
18. Factors associated with non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with new-onset atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II).
Steinberg BA; Shrader P; Thomas L; Ansell J; Fonarow GC; Gersh BJ; Hylek E; Kowey PR; Mahaffey KW; O'Brien EC; Singer DE; Peterson ED; Piccini JP;
Am Heart J; 2017 Jul; 189():40-47. PubMed ID: 28625380
[TBL] [Abstract][Full Text] [Related]
19. 'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey.
Lip GY; Laroche C; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Ioachim PM; Tica O; Boriani G; Cimaglia P; Diemberger I; Hellum CF; Mortensen B; Maggioni AP
Am J Med; 2014 Jun; 127(6):519-29.e1. PubMed ID: 24486284
[TBL] [Abstract][Full Text] [Related]
20. Non-permanent atrial fibrillation and oral anticoagulant therapy are related to survival during 10years after first-ever ischemic stroke.
Baturova MA; Lindgren A; Carlson J; Shubik YV; Bertil Olsson S; Platonov PG
Int J Cardiol; 2017 Apr; 232():134-139. PubMed ID: 28132778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
